Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes

A novel composite liposomal system co-encapsulating paclitaxel (PTX) with chloroquine phosphate (CQ) was designed for treating PTX-resistant carcinoma. It was confirmed that liposomal CQ can sensitize PTX by means of autophagy inhibition and competitively binding with multidrug-resistance transporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Menghua, Xu, Yuzhen, Qiu, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622487/
https://www.ncbi.nlm.nih.gov/pubmed/26543365
http://dx.doi.org/10.2147/IJN.S91463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622487/
https://www.ncbi.nlm.nih.gov/pubmed/26543365
http://dx.doi.org/10.2147/IJN.S91463

Ejemplares similares